Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 66 entries
View as:

A Study to Investigate the Safety and Tolerability of SCR-6920 Capsule in Patients With Advanced Malignant Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05528055 Org: User:
Start: 05/18/22 End: 10/31/27 Due: 10/31/28

Evaluation of SSD8432 and Ritonavir in Adult Subjects With COVID-19 Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT05373446 Org: User:
Start: 05/20/22 End: 03/31/23 Due: 03/31/24

Drug-Drug Interaction Study of Itraconazole, Rifampicin and Midazolam With SIM0417/Ritonavir in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05665647 Org: User:
Start: 12/29/22 End: 02/14/23 Due: 02/14/24

Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT02430350 Org: User:
Start: 05/31/15 End: 12/31/16 Due: 12/31/17

A Study of Docetaxel Polymeric Micelles for Injection in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05254665 Org: User:
Start: 02/28/22 End: 03/31/24 Due: 03/31/25

The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration.

Phase: N/A Priority: Normal
NCT ID: NCT02283476 Org: User:
Start: 11/30/14 End: 11/30/17 Due: 11/30/18

Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRI

Phase: N/A Priority: Normal
NCT ID: NCT01893151 Org: User:
Start: 07/31/12 End: 12/31/15 Due: 12/31/16

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC

Phase: N/A Priority: Normal
NCT ID: NCT06186414 Org: User:
Start: 01/23/24 End: 12/31/30 Due: 12/31/31

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06792552 Org: User:
Start: 02/26/25 End: 08/31/28 Due: 08/31/29

A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural Effusions

Phase: N/A Priority: Normal
NCT ID: NCT04914598 Org: User:
Start: 05/31/21 End: 10/30/23 Due: 10/30/24

To Evaluate SSD8432/Ritonavir in Adults With COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05373433 Org: User:
Start: 05/26/22 End: 10/31/23 Due: 10/31/24

A Clinical Study to Evaluate the Efficacy and Safety of SIM0417 Orally Co-Administered With Ritonavir in Symptomatic Adult Participants With Mild to Moderate COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05506176 Org: User:
Start: 08/19/22 End: 03/21/23 Due: 03/21/24

Bendamustine Hydrochloride Injection for Initial Treatment of Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01109264 Org: User:
Start: 03/31/10 End: 08/31/13 Due: 08/31/14

Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of Simotinib Hydrochloride in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01469910 Org: User:
Start: 09/30/11 End: 06/30/12 Due: 06/30/13

Safety and Pharmacokinetics of SIM0417 Combined With Ritonavir in Healthy Elderly Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05826249 Org: User:
Start: 04/07/23 End: 11/30/23 Due: 11/30/24

Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously

Phase: N/A Priority: Normal
NCT ID: NCT02805010 Org: User:
Start: 10/31/16 End: 02/28/17 Due: 02/28/18

Evaluation of TRILACICLIB in Chinese Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC) for Chemotherapy-induced Myelosuppression, Antitumor Effects of Combination Regimens, and Safety in a Real-world Study

Phase: N/A Priority: Normal
NCT ID: NCT05071703 Org: User:
Start: 08/11/21 End: 11/30/22 Due: 11/30/23

Hepatic Impairment and Renal Impairment Study of SIM0417 Combined With Ritonavir

Phase: N/A Priority: Normal
NCT ID: NCT05731804 Org: User:
Start: 03/01/23 End: 12/31/23 Due: 12/31/24

A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT02722694 Org: User:
Start: 08/31/16 End: 12/31/17 Due: 12/31/18

A Study of SIM0270 Combined with Everolimus Vs. Treatment of Physician's Choice in Patients with ER+/HER2- Advanced Breast Cancer (SIMRISE)

Phase: N/A Priority: Normal
NCT ID: NCT06680921 Org: User:
Start: 11/14/24 End: 08/31/28 Due: 08/31/29

Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02275299 Org: User:
Start: 09/30/13 End: 02/29/16 Due: 02/28/17

The Tolerability, Safety, and PK Characteristics of SIM1910-09 in Healthy Chinese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05200728 Org: User:
Start: 12/06/21 End: 03/23/23 Due: 03/23/24

Study of SIM0501 Alone and in Combination in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06331559 Org: User:
Start: 03/19/24 End: 12/31/27 Due: 12/31/28

A Phase I Study of SIM0388 in Participants With Malignant Ascites.

Phase: N/A Priority: Normal
NCT ID: NCT07007988 Org: User:
Start: 04/24/25 End: 12/31/27 Due: 12/31/28

A Phase 1b Study of Sevacizumab in Combination With Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT03763123 Org: User:
Start: 04/24/18 End: 12/31/20 Due: 12/31/21